---
title: "Anbio Biotechnology (NNNN.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/NNNN.US/norm.md"
symbol: "NNNN.US"
name: "Anbio Biotechnology"
parent: "https://longbridge.com/zh-HK/quote/NNNN.US.md"
datetime: "2026-03-04T01:38:10.745Z"
locales:
  - [en](https://longbridge.com/en/quote/NNNN.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NNNN.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NNNN.US/norm.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/NNNN.US/norm.md) | [简体中文](https://longbridge.com/zh-CN/quote/NNNN.US/norm.md)


# Anbio Biotechnology (NNNN.US) — 財務報表

## 損益表 (USD)

| 指標 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | 0.0437 | 0.0437 | -0.0145 | -0.0145 | 0.0425 |
| ROE | 27.57% | 33.95% | -14.24% | -13.75% | 39.06% |
| 營業收入 | 2.29M | 2.29M | 1.17M | 1.17M | 2.92M |
| 凈利潤 | 1.90M | 1.90M | -611901.00 | -611901.00 | 1.80M |
| 營業利潤 | 1.68M | 1.68M | -801499.00 | -801499.00 | 1.80M |
| 毛利率 | 92.32% | 92.32% | 84.55% | 84.55% | 66.85% |
| 凈利率 | 82.84% | 82.84% | -52.40% | -52.40% | 61.48% |
| 利潤含金量 | - | - | -108.22% | -108.22% | 600.63% |

## 資產負債表 (USD)

| 指標 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| 資產與負債 | 27.68M | 27.68M | 18.92M | 18.92M | 18.94M |
| 權益乘數 | 1.00 | 1.00 | 1.10 | 1.10 | 1.03 |
| 每股凈資產 | 0.6277 | 0.6277 | 0.4065 | 0.4065 | 0.4354 |
| 資產周轉率 | 0.2969 | 0.3240 | 0.4713 | 0.5092 | 0.5529 |
| 現金及短投 | 13.43M | 13.43M | 11.76M | 11.76M | 10.31M |
| 存貨與應收 | - | - | - | - | - |
| 長期投資 | - | - | - | - | - |
| 凈債務 | -13.43M | -13.43M | -11.76M | -11.76M | -10.31M |

## 現金流量表 (USD)

| 指標 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| 經營現金流 | - | - | 740645.00 | 740645.00 | 299549.00 |
| 投資現金流 | - | - | 99465.00 | 99465.00 | 69086.00 |
| 融資現金流 | - | - | -114875.00 | -114875.00 | -57428.00 |
| 自由現金流 | - | - | -500937.00 | 2.38M | 1.12M |
| 現金流充裕率 | - | - | - | - | - |
| 舉債與償債 | - | - | - | - | - |
| 資本支出 | - | - | - | - | - |